Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleComparison of 60 or 90 mg/m<sup>2</sup> of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.AuthorsDevillier, Raynier; Bertoli, Sarah; Prébet, Thomas; Huguet, Françoise; Etienne, Anne; Charbonnier, Aude; Rey, Jérôme; Delabesse, Eric; D'Incan, Evelyne; Huynh, Anne; Blaise, Didier; Récher, Christian; Vey, NorbertPublicationAmerican Journal of Hematology, 2015, Vol 90, Issue 2, pE29ISSN0361-8609Publication typeArticleDOI10.1002/ajh.23884